| Literature DB >> 23142081 |
Sung Jin Kim1, Michael A DeStefano, Won Jun Oh, Chang-chih Wu, Nicole M Vega-Cotto, Monica Finlan, Dou Liu, Bing Su, Estela Jacinto.
Abstract
The mammalian target of rapamycin (mTOR) integrates signals from nutrients and insulin via two distinct complexes, mTORC1 and mTORC2. Disruption of mTORC2 impairs the insulin-induced activation of Akt, an mTORC2 substrate. Here, we found that mTORC2 can also regulate insulin signaling at the level of insulin receptor substrate-1 (IRS-1). Despite phosphorylation at the mTORC1-mediated serine sites, which supposedly triggers IRS-1 downregulation, inactive IRS-1 accumulated in mTORC2-disrupted cells. Defective IRS-1 degradation was due to attenuated expression and phosphorylation of the ubiquitin ligase substrate-targeting subunit, Fbw8. mTORC2 stabilizes Fbw8 by phosphorylation at Ser86, allowing the insulin-induced translocation of Fbw8 to the cytosol where it mediates IRS-1 degradation. Thus, mTORC2 negatively feeds back to IRS-1 via control of Fbw8 stability and localization. Our findings reveal that in addition to persistent mTORC1 signaling, heightened mTORC2 signals can promote insulin resistance due to mTORC2-mediated degradation of IRS-1.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23142081 PMCID: PMC3534931 DOI: 10.1016/j.molcel.2012.09.029
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970